Milestone drug approvals failed to boost Biogen’s growth. BIIB Shares rose early Friday as analysts analyzed Thursday’s actions …
Copyright ©️ All rights reserved. | US Global Health
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.